Stay updated on ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.

Latest updates to the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, representing a minor update to the study record display.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page displays revision v3.6.3, indicating a small administrative update to the ClinicalTrials.gov record rather than changes to the study data.SummaryDifference0.1%

- Check40 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, reflecting a new site revision. This change does not modify any study information or page content.SummaryDifference0.1%

- Check54 days agoChange DetectedA recruitment status update indicates the study is no longer enrolling participants. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision label updated to v3.6.0, with the old v3.5.5 removed; the Intervention/Treatment heading appears as an addition while the previous Intervention / Treatment heading was removed.SummaryDifference0.4%

- Check61 days agoChange DetectedThe page footer's Revision label was updated from v3.5.4 to v3.5.5, indicating a new build/version of the site. This change is cosmetic and relates to site versioning rather than any study data.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be a minor update to the page structure or template rather than content.SummaryDifference0.1%

Stay in the know with updates to ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.